Rivaroxaban (Xarelto®)
Supply of Rivaroxaban (Xarelto®) in a range of presentations to health boards across NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£2,363,714
Published
9 Dec 2020
Closes
9 Dec 2020
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Rivaroxaban (Xarelto®)
£2,363,714
The Supply of Rivaroxaban (Xarelto®) in a range of presentations to health boards across NHS Scotland. The Authority has awarded a single supplier framework agreement for the requirement.
Delivery: United Kingdom, Scotland
Documents
Unlock document linkRivaroxaban (Xarelto®)
Not provided
Supply of Rivaroxaban (Xarelto®) in a range of presentations to health boards across NHS Scotland.
Award notice · Web page
Rivaroxaban (Xarelto®)
Not provided
Supply of Rivaroxaban (Xarelto®) in a range of presentations to health boards across NHS Scotland.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.